The meeting is scheduled for October 07, 2026. The mode is physical and the location is Mumbai. A specific time was not disclosed.
The purpose of the event is for the company's officials to participate in a meeting with investors, as per the standard disclosure for such interactions.
The document does not specify if the meeting is scheduled before or after an earnings announcement.
Management participants and their designations were not provided in the disclosure.
The company states that relevant Press Releases and Investor Presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and on stock exchange websites. It does not mention the availability of a transcript or recording.
The company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
Additional Notes Section
The disclosure is a formal regulatory filing made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The document includes a note that changes to the meeting may occur due to exigencies on the part of the company or the investors.
No financial data, guidance, or strategic updates were disclosed in this announcement; it is purely an intimation of a scheduled engagement.
The letter was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head – Legal (Membership No. A33861).
